Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Haferlach

Showing results (281-290 of 597) with videos related to

Pageof 60
Sort By:
Haematologica|April 19, 2012
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflowSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
Blood|April 14, 2012
PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cellsElena A Federzoni, Peter J M Valk, Bruce E Torbett, et al.
Hematological Oncology|August 24, 2012
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasmAndrea Piccin, Enrico Morello, Mirija Svaldi, et al.
Leukemia|April 29, 2023
AML classification in the year 2023: How to avoid a Babylonian confusion of languagesSandra Huber, Constance Baer, Stephan Hutter, et al.
Blood|May 17, 2008
Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptorFrank Breitenbuecher, Susanne Schnittger, Rebekka Grundler, et al.
Genes, Chromosomes & Cancer|March 13, 2014
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%Verena Mühlbacher, Melanie Zenger, Susanne Schnittger, et al.
Blood|July 28, 2012
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progressionHan-Yu Chuang, Laura Rassenti, Michelle Salcedo, et al.
Nature Communications|July 20, 2023
Computational analysis of peripheral blood smears detects disease-associated cytomorphologiesJosé Guilherme de Almeida, Emma Gudgin, Martin Besser, et al.
Leukemia|March 19, 2026
Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal originJana Wobst, Henning Ruge, Sara Senk, et al.
Leukemia & Lymphoma|September 24, 2016
Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2Silvan Francke, Anna Mies, Manja Meggendorfer, et al.
Pageof 60

Showing results (281-290 of 597) with videos related to

Sort By:
Pageof 60
Haematologica|April 19, 2012
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflowSusanne Schnittger, Ulrike Bacher, Christiane Eder, et al.
Blood|April 14, 2012
PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cellsElena A Federzoni, Peter J M Valk, Bruce E Torbett, et al.
Hematological Oncology|August 24, 2012
Post-transplant lymphoproliferative disease of donor origin, following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasmAndrea Piccin, Enrico Morello, Mirija Svaldi, et al.
Leukemia|April 29, 2023
AML classification in the year 2023: How to avoid a Babylonian confusion of languagesSandra Huber, Constance Baer, Stephan Hutter, et al.
Blood|May 17, 2008
Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptorFrank Breitenbuecher, Susanne Schnittger, Rebekka Grundler, et al.
Genes, Chromosomes & Cancer|March 13, 2014
Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%Verena Mühlbacher, Melanie Zenger, Susanne Schnittger, et al.
Blood|July 28, 2012
Subnetwork-based analysis of chronic lymphocytic leukemia identifies pathways that associate with disease progressionHan-Yu Chuang, Laura Rassenti, Michelle Salcedo, et al.
Nature Communications|July 20, 2023
Computational analysis of peripheral blood smears detects disease-associated cytomorphologiesJosé Guilherme de Almeida, Emma Gudgin, Martin Besser, et al.
Leukemia|March 19, 2026
Multiple myeloma with concomitant chronic lymphocytic leukemia: evidence for independent clonal originJana Wobst, Henning Ruge, Sara Senk, et al.
Leukemia & Lymphoma|September 24, 2016
Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2Silvan Francke, Anna Mies, Manja Meggendorfer, et al.
Pageof 60